Safety and Efficacy Study of HER2/Neu (E75) Vaccine in Node-Positive Breast Cancer Patients
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: BIOLOGICAL: E75 + GM-CSF vaccine
Sponsor: COL George Peoples, MD, FACS
Collaborators: Uniformed Services University of the Health Sciences